Literature DB >> 1440461

A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients.

M Robson1, J Abbott, K Webb, M Dodd, J Walsworth-Bell.   

Abstract

BACKGROUND: There is little information on the costs of running an adult cystic fibrosis centre. The aim of this study was to provide detailed costs to assist funding and planning for these patients.
METHODS: The cost of a regional adult cystic fibrosis centre serving 119 cystic fibrosis patients, categorised according to four treatment regimens, was determined. District health authority, family health service authority, and voluntary resources used from April 1989 to March 1990 were determined, with appropriate bases for allocation of costs and patient based costs from local information.
RESULTS: The total annual cost of treating the 119 patients was 980,646 pounds, with an average cost 8241 pounds per patient. An outpatient reviewed at three monthly intervals cost 2792 pounds a year; an outpatient receiving intravenous antibiotics cost 8606 pounds; an inpatient receiving intravenous antibiotics cost 13,501 pounds; and a patient needing a high level of care cost 19,955 pounds. Medication accounted for 57% (561,395 pounds) of the total cost.
CONCLUSIONS: This analysis has helped us to secure funding for patients with cystic fibrosis and it facilitates the prediction of future requirements. The study also indicates the limitations of using average patient costs and difficulties as a result of the poorly structured British National Health Service accounting and information systems.

Entities:  

Mesh:

Year:  1992        PMID: 1440461      PMCID: PMC474799          DOI: 10.1136/thx.47.9.684

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

Review 1.  Managing adults with cystic fibrosis.

Authors:  M E Hodson
Journal:  BMJ       Date:  1989-02-25

Review 2.  The difficulties of treating cystic fibrosis in adults.

Authors:  A K Webb
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

3.  Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80.

Authors:  P Phelan; E Hey
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

  3 in total
  28 in total

1.  The cost of care in cystic fibrosis.

Authors:  D J Shale
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

2.  Potential benefits of the UK Cystic Fibrosis Database.

Authors:  G Mehta; E J Sims; F Culross; J D McCormick; A Mehta
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

3.  Development of a modern adult cystic fibrosis centre in Manchester.

Authors:  A Kevin Webb; Roy Dudley-Southern; Andrew M Jones
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

4.  Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.

Authors:  Lisa A Carmody; Jiangchao Zhao; Patrick D Schloss; Joseph F Petrosino; Susan Murray; Vincent B Young; Jun Z Li; John J LiPuma
Journal:  Ann Am Thorac Soc       Date:  2013-06

5.  Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

Authors:  M F Wildhagen; J B Verheij; J G Verzijl; H B Hilderink; L Kooij; T Tijmstra; L P ten Kate; J Gerritsen; W Bakker; J D Habbema; F Habbema
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 6.  Cystic fibrosis: transition from paediatric to adult physician's care.

Authors:  L I Landau
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

Review 7.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Screening for carriers of cystic fibrosis--a general practitioner's perspective.

Authors:  M Modell
Journal:  BMJ       Date:  1993-10-02

9.  Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire.

Authors:  S Walters; J Britton; M E Hodson
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

10.  [Cost analysis for ambulatory treatment of cystic fibrosis patients in Germany. Overview of the prospective study results].

Authors:  Daniela Eidt; Thomas Mittendorf; Thomas O F Wagner; Andreas Reimann; J-Matthias Graf von der Schulenburg
Journal:  Med Klin (Munich)       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.